News | March 17, 2008

Bristol-Myers Squibb Medical Imaging Renamed Lantheus Medical Imaging

March 18, 2008 – Today Bristol-Myers Squibb Medical Imaging introduced its new name by launching Lantheus Medical Imaging, marking the first time in the company’s 50-year history that it will operate as an independent company.

The launch builds on the momentum created by the acquisition of the business by Avista Capital Partners in January of this year. The Massachusetts-based company, acquired by Avista Capital Partners in January 2008, will continue to provide medical imaging products for nuclear and ultrasound cardiovascular diagnostic imaging procedures, including Cardiolite (Kit for the Preparation of Technetium Tc99m Sestamibi for Injection), DEFINITY Vial for (Perflutren Lipid Microsphere) Injectable Suspension and TechneLite (Technetium Tc99m Generator).

Lantheus Medical Imaging’s new President and CEO Don Kiepert said, “Lantheus Medical Imaging is well-positioned for growth with a market-leading product portfolio, promising pipeline and a world-class organization committed to the field of medical imaging. Our people are passionate about developing innovative, clinically meaningful diagnostic tools that enhance and improve patient care.”

Before joining Lantheus Medical Imaging, Kiepert was the founder and former Chairman, CEO and President of Point Therapeutics since 1996. Prior to that he was president and CEO of Chartwell Home Therapies, a home infusion services company, from 1989 to 1996. Kiepert also started and managed several health care companies and worked in various management positions at Baxter Travenol, Inc. Kiepert received his M.S. degree in clinical pharmacy from Purdue University.

For more information: www.lantheus.com

Related Content

Study Finds No Evidence that Gadolinium Causes Neurologic Harm

MR images through, A, C, E, basal ganglia and, B, D, F, posterior fossa at level of dentate nucleus. Images are shown for, A, B, control group patient 4, and the, C, D, first and, E, F, last examinations performed in contrast group patient 13. Regions of interest used in quantification of signal intensity are shown as dashed lines for globus pallidus (green), thalamus (blue), dentate nucleus (yellow), and pons (red).

News | Contrast Media | January 11, 2018
January 11, 2018 — There is no evidence that accumulation in the brain of the element gadolinium speeds cognitive dec
Male Triathletes May Be Putting Their Heart Health at Risk
News | Cardiac Imaging | January 09, 2018
Competitive male triathletes face a higher risk of a potentially harmful heart condition called myocardial fibrosis,...
Videos | Magnetic Resonance Imaging (MRI) | December 19, 2017
Emanuel Kanal, M.D., director of MRI services and professor of radiology and neuroradiology at the University of Pitt
The FDA issued new warnings on MRI gadolinium contrast agents. (GBCAs)

The FDA issued new warnings on MRI gadolinium contrast agents. 

Feature | Magnetic Resonance Imaging (MRI) | December 19, 2017
The U.S.
Brainlab Contrast Clearance Analysis Software Receives FDA 510(k) Clearance
Technology | Contrast Media | December 12, 2017
Brainlab announced U.S. Food and Drug Administration (FDA) clearance of its Contrast Clearance Analysis methodology,...
Sectra Offers Gadolinium Tracking Functionality in DoseTrack Software
Technology | Contrast Media | December 11, 2017
December 11, 2017 — Sectra recently announced the global introduction of gadolinium tracking in its dose monitoring s
Videos | Magnetic Resonance Imaging (MRI) | December 07, 2017
Max Wintermark, M.D., professor of radiology and chief of neuroradiology, Stanford Hospital and Clinics, discussed MR
Guerbet to Participate in French Interventional Radiology Conference
News | Contrast Media | October 10, 2017
Guerbet announced it will be taking part in the 65th edition of the Journées Francophones de Radiologie (JFR) that will...
Trends in contrast media used in magnetic resonance imaging and computed tomography

Image courtesy of Bayer

Feature | Contrast Media | October 04, 2017 | By Dave Fornell
Over the past decade, several clinical studies have shown gadolinium-based magnetic resonance imaging (MRI) contrast...
Overlay Init